兰索拉唑

中文名称： 兰索拉唑 中文别名： 2-(((3-甲基-4-(2,2,2-三氟乙氧基)-2-吡啶基)甲基)亚磺酰基)-1H-苯并咪唑; 达克普隆 英文名称： lansoprazole 英文别名： 2-{[[3-methyl-4-(2,2,2-trifluoroethoxy)2-pyridinyl]methyl]sulfonyl}1H-benzimidazole; 2-({[3-methyl-4-(2,2,2-trifluoroethoxy)pyridin-2-yl]methyl}sulfinyl)-1H-benzimidazole; 1-(1H-benzimidazol-2-yl)-2-[3-methyl-4-(2,2,2-trifluoroethoxy)-2-pyridyl]ethanone; lansoprazile CAS号： 103577-45-3 分子式： C17H14F3N3O2 分子量： 349.3072 InChI： InChI=1/C17H14F3N3O2/c1-10-13(21-7-6-15(10)25-9-17(18,19)20)8-14(24)16-22-11-4-2-3-5-12(11)23-16/h2-7H,8-9H2,1H3,(H,22,23) 分子结构： [兰索拉唑 103577-45-3] 密度： 1.376g/cm3 沸点： 504.9°C at 760 mmHg 闪点： 259.2°C 蒸汽压： 2.55E-10mmHg at 25°C 产品用途： 用于治疗十二指肠溃疡等症

Beijing HOPE Pharmaceutical Co., Ltd. (stock number 836438), founded in 2005 and located in Beijing Economic and technological development Zone. It is a high-tech enterprise focused on research and development of chemical drug . Hope got self-support imp & exp rights, dedicated to R&D, manufacture, sales and technology transfer service of APIs, intermediates and preparations. Hope owns a high-level R&D team and has established a strict scientific research management system and a diversified service system. Through years of technical accumulation and steady development, Hope has been nam